| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |